Atrial Fibrillation News and Research

RSS
Atrial fibrillation (AF) is the most common arrhythmia. An arrhythmia is a problem with the speed or rhythm of the heartbeat. A disorder in the heart’s electrical system causes AF and other types of arrhythmia. AF occurs when rapid, disorganized electrical signals in the heart’s two upper chambers, called the atria, cause them to contract very fast and irregularly (this is called fibrillation). As a result, blood pools in the atria and isn’t pumped completely into the heart’s two lower chambers, called the ventricles. When this happens, the heart’s upper and lower chambers don’t work together as they should. Often, people who have AF may not even feel symptoms. However, even when not noticed, AF can lead to an increased risk of stroke. In many patients, particularly when the rhythm is extremely rapid, AF can cause chest pain, heart attack, or heart failure. AF may occur rarely or every now and then, or it may become a persistent or permanent heart rhythm lasting for years.
Stanford researchers find how neurons work together to control movement in people with paralysis

Stanford researchers find how neurons work together to control movement in people with paralysis

Statins benefit patients undergoing major lung resection, lower major complications

Statins benefit patients undergoing major lung resection, lower major complications

Atrial fibrillation patients who stop blood thinners before elective surgery have less risk of major bleeding

Atrial fibrillation patients who stop blood thinners before elective surgery have less risk of major bleeding

AliveCor Mobile ECG now available in Canada

AliveCor Mobile ECG now available in Canada

Scientists develop computational method to study link between birth month and disease risk

Scientists develop computational method to study link between birth month and disease risk

Ibrutinib shows promise in CLL/SLL

Ibrutinib shows promise in CLL/SLL

Ibrutinib (IMBRUVICA) improves survival in treatment-naïve patients with chronic lymphocytic leukemia

Ibrutinib (IMBRUVICA) improves survival in treatment-naïve patients with chronic lymphocytic leukemia

Expert report highlights urgent action needed to lessen the future impact of Atrial Fibrillation in Europe

Expert report highlights urgent action needed to lessen the future impact of Atrial Fibrillation in Europe

Using earlier surgical intervention more beneficial to patient with degenerative mitral valve disease

Using earlier surgical intervention more beneficial to patient with degenerative mitral valve disease

Pharmacyclics's Phase III RESONATE™ trial shows adherence to 420mg dose of IMBRUVICA improves outcomes in CLL patients

Pharmacyclics's Phase III RESONATE™ trial shows adherence to 420mg dose of IMBRUVICA improves outcomes in CLL patients

Pharmacyclics’ Ibrutinib Phase Ib/II data show ibrutinib may be safe and effective in patients with cGVHD

Pharmacyclics’ Ibrutinib Phase Ib/II data show ibrutinib may be safe and effective in patients with cGVHD

Phase III HELIOS trial results show ibrutinib combination therapy improves outcomes  in CLL/SLL patients

Phase III HELIOS trial results show ibrutinib combination therapy improves outcomes in CLL/SLL patients

Pharmacyclics initiates ibrutinib-MEDI4736 combination multi-center study for R/R DLBCL or FL

Pharmacyclics initiates ibrutinib-MEDI4736 combination multi-center study for R/R DLBCL or FL

Newer anticoagulant medication may increase risk of GI bleeding in older patients

Newer anticoagulant medication may increase risk of GI bleeding in older patients

Janssen, Bayer HealthCare initiate CALLISTO program to study rivaroxaban in patients with active cancer

Janssen, Bayer HealthCare initiate CALLISTO program to study rivaroxaban in patients with active cancer

COPD associated with increased mortality in patients with atrial fibrillation, but not stroke

COPD associated with increased mortality in patients with atrial fibrillation, but not stroke

Researchers use American College of Cardiology registry to improve cardiovascular care delivery in India

Researchers use American College of Cardiology registry to improve cardiovascular care delivery in India

Cardiology researchers uncover new evidence that relates to increased risk of stroke

Cardiology researchers uncover new evidence that relates to increased risk of stroke

Post-operative atrial fibrillation can significantly increase risk of heart attack or stroke

Post-operative atrial fibrillation can significantly increase risk of heart attack or stroke

No data exists to support long-term efficacy, safety of e-cigarettes as smoking cessation tool

No data exists to support long-term efficacy, safety of e-cigarettes as smoking cessation tool

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.